Humedix

At a glance

Humedix filed 49 disclosures in the last 12 months, including 4 buyback, 3 insider and 3 5% holder. The most recent key filing was on Sep 10.

Revenue for 2025 was ₩170B, up 5.1% on 2024. Operating margin was 24.9% against 26.7% a year earlier. Debt was 8% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩90.9B and operating profit of ₩20.6B.

The 2025 annual report lists 377 employees with an average tenure of 4.3 years and average pay of ₩56.7M, #1136 of 1,829 listed companies by average pay. Its 7 directors and auditors were paid ₩139M each on average. It paid ₩920 per common share in cash dividends, against ₩630 a year earlier (+46%). ㈜휴온스글로벌 and related parties held 37.45% at year end.

From the 2025 annual report

Staff: 377 (229 men, 148 women), of whom 4 on fixed-term contracts. Total pay for the year: ₩21.3B. Directors and auditors: 7, paid ₩975M in total.

Dividends (common shares)

Largest shareholder

㈜휴온스글로벌 holds 36.08%; with 10 related parties the group holds 37.45% of common shares at year end (from 37.50% at the start of the year).

Auditor: 삼정회계법인 · opinion: Unqualified.

Rankings: Low debt #14 of 1,372 · Operating margin #36 of 1,376

Source: 2025 annual business report (DART). How figures are combined

Financial summary